Although the Trump administration has already declared a political victory by standing up to the hospital lobby, there's still a lot that could happen between now and the rule's effective date.
These are some of the highlights from our 2019 coverage of news, topics, and trends that matter to CEOs and other senior strategy leaders at healthcare payer and provider organizations.
The administration points to statutory language, including definitions amended by the ACA, as preventing that FDA from allowing states to import biologics.
The highly anticipated decision sends the dispute back to the lower court to further analyze which provisions of the law, if any, may be severed from the central mandate.
